224 related articles for article (PubMed ID: 21303248)
1. Overview of HIV among injection drug users in New York City: critical next steps to eliminate racial/ethnic disparities.
Amesty S; Rivera AV; Fuller CM
Subst Use Misuse; 2011; 46(2-3):285-94. PubMed ID: 21303248
[TBL] [Abstract][Full Text] [Related]
2. Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs.
Des Jarlais DC; Arasteh K; Hagan H; McKnight C; Perlman DC; Friedman SR
Am J Public Health; 2009 Oct; 99 Suppl 2(Suppl 2):S445-51. PubMed ID: 19797757
[TBL] [Abstract][Full Text] [Related]
3. Similarities and differences by race/ethnicity in changes of HIV seroprevalence and related behaviors among drug injectors in New York City, 1991-1996.
Friedman SR; Chapman TF; Perlis TE; Rockwell R; Paone D; Sotheran JL; Des Jarlais DC
J Acquir Immune Defic Syndr; 1999 Sep; 22(1):83-91. PubMed ID: 10534151
[TBL] [Abstract][Full Text] [Related]
4. Will "Combined Prevention" Eliminate Racial/Ethnic Disparities in HIV Infection among Persons Who Inject Drugs in New York City?
Des Jarlais D; Arasteh K; McKnight C; Feelemyer J; Hagan H; Cooper H; Campbell A; Tross S; Perlman D
PLoS One; 2015; 10(5):e0126180. PubMed ID: 25965957
[TBL] [Abstract][Full Text] [Related]
5. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City.
Fuller CM; Galea S; Caceres W; Blaney S; Sisco S; Vlahov D
Am J Public Health; 2007 Jan; 97(1):117-24. PubMed ID: 17138929
[TBL] [Abstract][Full Text] [Related]
6. "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001.
Des Jarlais DC; Perlis T; Arasteh K; Hagan H; Milliken J; Braine N; Yancovitz S; Mildvan D; Perlman DC; Maslow C; Friedman SR
J Acquir Immune Defic Syndr; 2004 Feb; 35(2):158-66. PubMed ID: 14722449
[TBL] [Abstract][Full Text] [Related]
7. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
Neaigus A; Zhao M; Gyarmathy VA; Cisek L; Friedman SR; Baxter RC
J Urban Health; 2008 May; 85(3):309-22. PubMed ID: 18340537
[TBL] [Abstract][Full Text] [Related]
8. New York City injection drug users' memories of syringe-sharing patterns and changes during the peak of the HIV/AIDS epidemic.
Rockwell R; Joseph H; Friedman SR
AIDS Behav; 2006 Nov; 10(6):691-8. PubMed ID: 16708274
[TBL] [Abstract][Full Text] [Related]
9. Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies.
Rudolph AE; Crawford ND; Ompad DC; Benjamin EO; Stern RJ; Fuller CM
J Am Pharm Assoc (2003); 2010 Mar-Apr 1; 50(2):140-7. PubMed ID: 20199954
[TBL] [Abstract][Full Text] [Related]
10. Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users.
Kottiri BJ; Friedman SR; Neaigus A; Curtis R; Des Jarlais DC
J Acquir Immune Defic Syndr; 2002 May; 30(1):95-104. PubMed ID: 12048369
[TBL] [Abstract][Full Text] [Related]
11. Randomized, community-based pharmacy intervention to expand services beyond sale of sterile syringes to injection drug users in pharmacies in New York City.
Crawford ND; Amesty S; Rivera AV; Harripersaud K; Turner A; Fuller CM
Am J Public Health; 2013 Sep; 103(9):1579-82. PubMed ID: 23865644
[TBL] [Abstract][Full Text] [Related]
12. Community characteristics associated with HIV risk among injection drug users in the San Francisco Bay Area: a multilevel analysis.
Bluthenthal RN; Do DP; Finch B; Martinez A; Edlin BR; Kral AH
J Urban Health; 2007 Sep; 84(5):653-66. PubMed ID: 17657607
[TBL] [Abstract][Full Text] [Related]
13. Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992.
Des Jarlais DC; Friedman SR; Sotheran JL; Wenston J; Marmor M; Yancovitz SR; Frank B; Beatrice S; Mildvan D
JAMA; 1994 Jan; 271(2):121-7. PubMed ID: 8264066
[TBL] [Abstract][Full Text] [Related]
14. Racial and ethnic changes in heroin injection in the United States: implications for the HIV/AIDS epidemic.
Broz D; Ouellet LJ
Drug Alcohol Depend; 2008 Apr; 94(1-3):221-33. PubMed ID: 18242879
[TBL] [Abstract][Full Text] [Related]
15. Continuing HIV risk in New York City injection drug users: the association of syringe source and syringe sharing.
Jenness SM; Hagan H; Liu KL; Wendel T; Murrill CS
Subst Use Misuse; 2011; 46(2-3):192-200. PubMed ID: 21303239
[TBL] [Abstract][Full Text] [Related]
16. HIV risks and seroprevalence among Mexican American injection drug users in California.
Martinez AN; Bluthenthal RN; Flynn NM; Anderson RL; Kral AH
AIDS Behav; 2011 Jan; 15(1):95-102. PubMed ID: 20020194
[TBL] [Abstract][Full Text] [Related]
17. Secondary syringe exchange among injection drug users.
Snead J; Downing M; Lorvick J; Garcia B; Thawley R; Kegeles S; Edlin BR
J Urban Health; 2003 Jun; 80(2):330-48. PubMed ID: 12791808
[TBL] [Abstract][Full Text] [Related]
18. HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years.
Des Jarlais DC; Arasteh K; Friedman SR
Subst Use Misuse; 2011; 46(2-3):131-9. PubMed ID: 21303233
[TBL] [Abstract][Full Text] [Related]
19. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
Bluthenthal RN; Malik MR; Grau LE; Singer M; Marshall P; Heimer R;
Addiction; 2004 Sep; 99(9):1136-46. PubMed ID: 15317634
[TBL] [Abstract][Full Text] [Related]
20. [A study on the risk and its determinants of HIV transmission by syringe sharing among HIV-positive drug users].
Bao Y; Zhang Y; Liang Y; Chen M; Sun J; Tan H
Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Jun; 49(6):513-7. PubMed ID: 26310336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
